Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Receivables (2016 - 2025)

Historic Receivables for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $190.5 million.

  • Prestige Consumer Healthcare's Receivables rose 1385.87% to $190.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $190.5 million, marking a year-over-year increase of 1385.87%. This contributed to the annual value of $194.3 million for FY2025, which is 990.98% up from last year.
  • According to the latest figures from Q4 2025, Prestige Consumer Healthcare's Receivables is $190.5 million, which was up 1385.87% from $199.0 million recorded in Q3 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Receivables peaked at $199.0 million during Q3 2025, and registered a low of $114.7 million during Q1 2021.
  • For the 5-year period, Prestige Consumer Healthcare's Receivables averaged around $160.1 million, with its median value being $161.0 million (2023).
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Receivables tumbled by 2381.53% in 2021, and later soared by 2167.76% in 2025.
  • Prestige Consumer Healthcare's Receivables (Quarter) stood at $134.3 million in 2021, then increased by 17.0% to $157.1 million in 2022, then increased by 10.95% to $174.3 million in 2023, then fell by 4.02% to $167.3 million in 2024, then rose by 13.86% to $190.5 million in 2025.
  • Its Receivables stands at $190.5 million for Q4 2025, versus $199.0 million for Q3 2025 and $168.4 million for Q2 2025.